|
|
Superior Specificity
PARAD/PARAD+, provides optimal arrhythmia detection and treatment for patients with implantable cardioverter defibrillators (ICDs). read more... |
|
99.9%1 intrinsic conduction SafeRTM, available in OVATIOTM implantable cardioverter defibrillators (ICDs), is the a pacing mode that utilizes all spontaneous conduction and only stimulates the right ventricle when truly necessary, thereby avoiding deleterious right ventricular stimulation. read more... |
1. “99.9% intrinsic AV conduction in 28/35 (80%) of patients of non-selected DDD patients” Anselme et al. First clinical results of AAIsafeR2, a new mode to prevent ventricular pacing. Heart Rhythm 2006; 2, supp 5; p4-99 (abs).
